ReliVet is a new business initiative of Reliance Life Sciences in the animal health sector, set up to offer advanced, world class, efficacious and quality products for the animal health market. Reliance Life Sciences envisions a future where its veterinary products and services will be readily available to pet owners, livestock producers, and veterinarians worldwide; enabling them to make informed decisions about animal health and well-being. Reliance Life Sciences strives to develop new and innovative healthcare solutions that address the unmet needs of animals and their caregivers, leveraging latest technologies and research in the field.
ReliVet Animal health products cover therapeutics, nutritional products and vaccines for both companion animals and livestock animals.
Become a trusted partner to veterinarians, pet owners, farmers and animal worldwide, by delivering high quality and competitively priced products and services.
Our mission at RELIVET is to improve the health and well-being of animals worldwide through innovative solutions and compassionate care.
We believe in working closely with our partners in the veterinary community to develop and deliver effective solutions that improve outcomes for animals and their caregivers. Our ultimate goal is to make a meaningful difference in the lives of animals and the people who love them, while contributing to the broader health and well-being of our planet.
Reliance Life Sciences is a research-driven organization, developing business opportunities in bio-therapeutics (plasma proteins, biosimilars and novel proteins), pharmaceuticals (later-generation, oncology generics), vaccines, clinical research services, regenerative medicine (stem cells therapies) and molecular medicine.
Reliance Life Sciences is part of the Promoter Group of Reliance Industries Limited. Reliance Life Sciences has launched five of the world’s first biosimilars, has the largest number of biosimilars in the market in India, and the highest number of biosimilars under development globally. It has the distinction of being the first integrated manufacturer of plasma proteins in South Asia. Reliance Life Sciences has catalysed the emergence of regenerative medicine in the country, and has the highest experience with cord blood stem cell transplants in India. RLS is one of the few centres in the world offering a specialized range of tests in molecular medicine and molecular genetics.
Reliance Life Sciences operates state-of-the-art facilities in the life sciences domain. The flagship facility is the Dhirubhai Ambani Life Sciences Centre (DALC) in Navi Mumbai, India. Spread over 20 acres, DALC is among the most diverse and integrated life sciences campuses in the world, housing world-scale and world- class manufacturing facilities approved by Indian and international regulatory agencies.
Today, Reliance Life Sciences is a fully- integrated life sciences industry player with in-house capabilities in research, pre-clinical and clinical development, process development, quality management, commercial-scale manufacturing and marketing.